Condensed Consolidated Statements of Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Treasury Stock	Accumulated Other Comprehensive Income / (Loss)	Retained Earnings
Beginning balance at Dec. 31, 2022	$ 23,988
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion adjustments of redeemable noncontrolling interest to redemption value	2,061
Net income / (loss) attributable to common stockholders	(209)
Ending balance at Mar. 31, 2023	25,840
Beginning balance (in shares) at Dec. 31, 2022		50,985,000
Beginning balance at Dec. 31, 2022	598,859	$ 510	$ 497,199	$ (83,993)	$ 0	$ 185,143
Beginning balance (in shares) at Dec. 31, 2022				1,533,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued in connection with equity-based plans (in shares)		270,000
Common stock issued in connection with equity-based plans	1,311	$ 3	1,308
Stock-based compensation expense	12,686		12,686
Accretion adjustments of redeemable noncontrolling interest to redemption value	(2,061)		(2,061)
Net income / (loss) attributable to common stockholders	14,416					14,416
Other comprehensive (loss) income	170				170
Ending balance (in shares) at Mar. 31, 2023		51,255,000
Ending balance at Mar. 31, 2023	625,381	$ 513	509,132	$ (83,993)	170	199,559
Ending balance (in shares) at Mar. 31, 2023				1,533,000
Beginning balance at Dec. 31, 2022	23,988
Ending balance at Jun. 30, 2023	27,868
Beginning balance (in shares) at Dec. 31, 2022		50,985,000
Beginning balance at Dec. 31, 2022	598,859	$ 510	497,199	$ (83,993)	0	185,143
Beginning balance (in shares) at Dec. 31, 2022				1,533,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Purchases of treasury stock (in shares)				134,255
Purchase of treasury stock				$ (6,700)
Other comprehensive (loss) income	828
Ending balance (in shares) at Jun. 30, 2023		51,525,000
Ending balance at Jun. 30, 2023	644,231	$ 515	518,249	$ (90,719)	828	215,358
Ending balance (in shares) at Jun. 30, 2023				1,667,000
Beginning balance at Mar. 31, 2023	25,840
Increase (Decrease) in Temporary Equity [Roll Forward]
Purchases of redeemable noncontrolling interest	(1,238)
Accretion adjustments of redeemable noncontrolling interest to redemption value	3,454
Net income / (loss) attributable to common stockholders	(188)
Ending balance at Jun. 30, 2023	27,868
Beginning balance (in shares) at Mar. 31, 2023		51,255,000
Beginning balance at Mar. 31, 2023	625,381	$ 513	509,132	$ (83,993)	170	199,559
Beginning balance (in shares) at Mar. 31, 2023				1,533,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued in connection with equity-based plans (in shares)		270,000
Common stock issued in connection with equity-based plans	202	$ 2	200
Purchases of treasury stock (in shares)				134,255
Purchase of treasury stock	(6,726)			$ (6,726)
Stock-based compensation expense	11,965		11,965
Purchases of redeemable noncontrolling interest	406		406
Accretion adjustments of redeemable noncontrolling interest to redemption value	(3,454)		(3,454)
Net income / (loss) attributable to common stockholders	15,799					15,799
Other comprehensive (loss) income	658				658
Ending balance (in shares) at Jun. 30, 2023		51,525,000
Ending balance at Jun. 30, 2023	644,231	$ 515	518,249	$ (90,719)	828	215,358
Ending balance (in shares) at Jun. 30, 2023				1,667,000
Beginning balance at Dec. 31, 2023	36,308
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion adjustments of redeemable noncontrolling interest to redemption value	1,595
Net income / (loss) attributable to common stockholders	(191)
Ending balance at Mar. 31, 2024	$ 37,712
Beginning balance (in shares) at Dec. 31, 2023	51,888,838	51,889,000
Beginning balance at Dec. 31, 2023	$ 688,546	$ 519	531,734	$ (111,291)	1,398	266,186
Beginning balance (in shares) at Dec. 31, 2023	2,020,663			2,021,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued in connection with equity-based plans (in shares)		224,000
Common stock issued in connection with equity-based plans	$ 6,356	$ 2	6,354
Stock-based compensation expense	11,339		11,339
Accretion adjustments of redeemable noncontrolling interest to redemption value	(1,595)		(1,595)
Net income / (loss) attributable to common stockholders	23,595					23,595
Other comprehensive (loss) income	(147)				(147)
Ending balance (in shares) at Mar. 31, 2024		52,113,000
Ending balance at Mar. 31, 2024	728,094	$ 521	547,832	$ (111,291)	1,251	289,781
Ending balance (in shares) at Mar. 31, 2024				2,021,000
Beginning balance at Dec. 31, 2023	36,308
Ending balance at Jun. 30, 2024	$ 37,933
Beginning balance (in shares) at Dec. 31, 2023	51,888,838	51,889,000
Beginning balance at Dec. 31, 2023	$ 688,546	$ 519	531,734	$ (111,291)	1,398	266,186
Beginning balance (in shares) at Dec. 31, 2023	2,020,663			2,021,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Purchases of treasury stock (in shares)				1,117,068
Purchase of treasury stock				$ (75,000)
Other comprehensive (loss) income	$ (303)
Ending balance (in shares) at Jun. 30, 2024	52,321,569	52,322,000
Ending balance at Jun. 30, 2024	$ 645,469	$ 523	506,850	$ (186,291)	1,095	323,292
Ending balance (in shares) at Jun. 30, 2024	3,137,731			3,138,000
Beginning balance at Mar. 31, 2024	$ 37,712
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion adjustments of redeemable noncontrolling interest to redemption value	1,212
Net income / (loss) attributable to common stockholders	(991)
Ending balance at Jun. 30, 2024	37,933
Beginning balance (in shares) at Mar. 31, 2024		52,113,000
Beginning balance at Mar. 31, 2024	728,094	$ 521	547,832	$ (111,291)	1,251	289,781
Beginning balance (in shares) at Mar. 31, 2024				2,021,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued in connection with equity-based plans (in shares)		209,000
Common stock issued in connection with equity-based plans	378	$ 2	376
Purchases of treasury stock (in shares)				1,117,068
Purchase of treasury stock	(75,559)		(559)	$ (75,000)
Tax withholding related to vesting of restricted stock units	(3,401)		(3,401)
Stock-based compensation expense	11,250		11,250
Accretion adjustments of redeemable noncontrolling interest to redemption value	(1,212)		(1,212)
Purchases of capped calls related to convertible senior notes, net of tax	(47,436)		(47,436)
Net income / (loss) attributable to common stockholders	33,511					33,511
Other comprehensive (loss) income	$ (156)				(156)
Ending balance (in shares) at Jun. 30, 2024	52,321,569	52,322,000
Ending balance at Jun. 30, 2024	$ 645,469	$ 523	$ 506,850	$ (186,291)	$ 1,095	$ 323,292
Ending balance (in shares) at Jun. 30, 2024	3,137,731			3,138,000